Antiresorptive treatments for corticosteroid-induced osteoporosis: a Bayesian network meta-analysis

Efficacy and safety of denosumab compared to bisphosphonates in improving bone strength in postmenopausal osteoporosis: a systematic review

(2019) T Chandran et al.   SINGAPORE MEDICAL JOURNAL

Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis

(2019) Zeina A. Yanbeiy et al.   Drug Design Development and Therapy

THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis

(2018) Athanasios D Anastasilakis et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial

(2018) Ken Iseri et al.   PLoS One

Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study

(2018) Kenneth G Saag et al.   Lancet Diabetes & Endocrinology

Glucocorticoid-Induced Osteoporosis

(2018) Lenore Buckley et al.   NEW ENGLAND JOURNAL OF MEDICINE

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

(2015) Brian Hutton et al.   ANNALS OF INTERNAL MEDICINE

Glucocorticoid-induced osteoporosis: who to treat with what agent?

(2014) René Rizzoli et al.   Nature Reviews Rheumatology

Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review

(2013) Erik F. Eriksen et al.   BONE

Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate

(2011) Philip N. Sambrook et al.   BONE

The Fracture Risk Assessment Tool (FRAX®): Applications in Clinical Practice

(2011) Nelson B. Watts   JOURNAL OF WOMENS HEALTH

Efficacy of Bisphosphonates in Reducing Fracture Risk in Postmenopausal Osteoporosis

(2009) John P. Bilezikian   AMERICAN JOURNAL OF MEDICINE

Glucocorticoids, osteocytes, and skeletal fragility: The role of bone vascularity

(2009) Robert S. Weinstein   BONE

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

(2009) David M Reid et al.   LANCET

Glucocorticoid-induced osteoporosis: treatment update and review

(2009) Lisa-Ann Fraser et al.   Therapeutic Advances in Musculoskeletal Disease